Brief: MiMedx Group Says Pursuing All Available Options To Keep AXIOFILL On Market

MiMedx

27/03/2024 12:19

March 27 (Reuters) - MiMedx Group Inc  MDXG.O :
    * MIMEDX PROVIDES UPDATE ON AXIOFILL® REQUEST FOR
DESIGNATION
(“RFD”) FROM FDA
    * MIMEDX GROUP INC - DO NOT CURRENTLY ANTICIPATE ONGOING
MATTER
RELATED TO AXIOFILL WILL REQUIRE US TO CHANGE OUR FULL YEAR 2024
FINANCIAL GUIDANCE
    * MIMEDX GROUP INC - RECEIVES DETERMINATION LETTER FROM FDA
STATING AXIOFILL DOES NOT QUALIFY FOR CLASSIFICATION AS AN HCT/P
UNDER SECTION 361
    * MIMEDX GROUP INC - MIMEDX CONTINUES TO PURSUE ALL
AVAILABLE
OPTIONS TO KEEP AXIOFILL ON MARKET

Source text for Eikon:  ID:nGNX9KJxbQ 
Further company coverage:  MDXG.O 

 ((Reuters.Briefs@thomsonreuters.com;))